BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15505987)

  • 21. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
    Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center.
    Bacigaluppi S; Gatto F; Anania P; Bragazzi NL; Rossi DC; Benvegnu G; Nazzari E; Spaziante R; Giusti M; Ferone D; Zona G
    Endocrine; 2016 Mar; 51(3):524-33. PubMed ID: 25982150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly.
    Colao A; De Rosa M; Pivonello R; Balestrieri A; Cappabianca P; Di Sarno A; Rochira V; Carani C; Lombardi G
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4193-7. PubMed ID: 12213870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function.
    Escobar-Morreale HF; Serrano-Gotarredona J; Avila S; Villar-Palasí J; Varela C; Sancho J
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2580-4. PubMed ID: 9661648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and metabolic characteristics of acromegalic patients with high IGF1/normal GH levels during somatostatin analog treatment.
    Matta M; Bongard V; Grunenwald S; Maiza JC; Bennet A; Caron P
    Eur J Endocrinol; 2011 Jun; 164(6):885-9. PubMed ID: 21471168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative somatostatin analogs treatment in acromegalic patients with macroadenomas. A meta-analysis.
    Zhang L; Wu X; Yan Y; Qian J; Lu Y; Luo C
    Brain Dev; 2015 Feb; 37(2):181-90. PubMed ID: 24815226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly.
    Colao A; Pivonello R; Cappabianca P; Briganti F; Tortora F; Auriemma RS; De Martino MC; Marzullo P; Lombardi G
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):342-9. PubMed ID: 16117824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of insulin resistance in acromegalic patients before and after treatment with somatostatin analogues.
    Ronchi CL; Orsi E; Giavoli C; Cappiello V; Epaminonda P; Beck-Peccoz P; Arosio M
    J Endocrinol Invest; 2003 Jun; 26(6):533-8. PubMed ID: 12952367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly.
    Gatto F; Feelders RA; van der Pas R; Kros JM; Waaijers M; Sprij-Mooij D; Neggers SJ; van der Lelij AJ; Minuto F; Lamberts SW; de Herder WW; Ferone D; Hofland LJ
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E66-71. PubMed ID: 23118420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy and safety of combined treatment of somatostatin analogs and pegvisomant in acromegaly.
    Neggers SJ; van Aken MO; Janssen JA; Feelders RA; de Herder WW; van der Lely AJ
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4598-601. PubMed ID: 17895318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
    Vural B; Ozkan S; Bodur H
    J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic hyperplasia: an unknown feature of acromegaly.
    Colao A; Marzullo P; Ferone D; Spiezia S; Cerbone G; Marinò V; Di Sarno A; Merola B; Lombardi G
    J Clin Endocrinol Metab; 1998 Mar; 83(3):775-9. PubMed ID: 9506725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum type III procollagen propeptide levels in acromegalic patients.
    Verde GG; Santi I; Chiodini P; Cozzi R; Dallabonzana D; Oppizzi G; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1406-10. PubMed ID: 2878008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menstrual irregularity in women with acromegaly.
    Kaltsas GA; Mukherjee JJ; Jenkins PJ; Satta MA; Islam N; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2731-5. PubMed ID: 10443669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum PSA levels are not affected by the menstrual cycle or the menopause, but are increased in subjects with polycystic ovary syndrome.
    Burelli A; Cionini R; Rinaldi E; Benelli E; Fiore E; Canale D; Bencivelli W; Nencetti C; Pinchera A; Pucci E
    J Endocrinol Invest; 2006 Apr; 29(4):308-12. PubMed ID: 16699296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
    Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.